DBTX
Income statement / Annual
Last year (2022), Decibel Therapeutics, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2022, Decibel Therapeutics, Inc.'s net income was -$63.01 M.
See Decibel Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$40.33 M
|
$29.85 M
|
$25.32 M
|
$29.41 M
|
$26.17 M
|
| General & Administrative
Expenses |
$23.63 M
|
$20.38 M
|
$14.24 M
|
$14.68 M
|
$11.69 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$23.63 M
|
$20.38 M
|
$14.24 M
|
$14.68 M
|
$11.69 M
|
| Other Expenses |
$0.00 |
$12,000.00 |
$171,000.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$63.96 M |
$50.23 M |
$39.56 M |
$44.08 M |
$37.86 M |
| Cost And Expenses |
$63.96 M |
$50.23 M |
$39.56 M |
$44.08 M |
$37.86 M |
| Interest Income |
$1.19 M |
$193,000.00 |
$55,000.00 |
$1.41 M |
$1.70 M |
| Interest Expense |
$1.19 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$1.46 M
|
$1.41 M
|
$1.64 M
|
$1.77 M
|
$1.47 M
|
| EBITDA |
-$62.50 M
|
-$48.82 M
|
-$39.56 M
|
-$42.31 M
|
-$36.39 M
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
$1.19 M
|
$205,000.00
|
$226,000.00
|
$1.41 M
|
$1.70 M
|
| Income Before Tax |
-$62.77 M |
-$50.03 M |
-$39.34 M |
-$42.67 M |
-$36.16 M |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$240,000.00 |
$1.80 M |
-$1.70 M |
-$1.41 M |
$1.70 M |
| Net Income |
-$63.01 M |
-$51.82 M |
-$37.64 M |
-$41.26 M |
-$36.16 M |
| Net Income Ratio |
0 |
0 |
0 |
0 |
0 |
| EPS |
-2.52 |
-2.38 |
-1.63 |
-5.61 |
-4.98 |
| EPS Diluted |
-2.52 |
-2.38 |
-1.63 |
-5.61 |
-4.98 |
| Weighted Average Shares
Out |
$24.96 M
|
$21.73 M
|
$23.12 M
|
$7.36 M
|
$7.26 M
|
| Weighted Average Shares
Out Diluted |
$24.96 M
|
$21.73 M
|
$23.12 M
|
$7.36 M
|
$7.26 M
|
| Link |
|
|
|
|
|
